Letters to the Editor: HLA-A2 transgenic mouse model: potential utility for development of an HCV vaccine
- 29 February 2000
- journal article
- other
- Published by Elsevier in Journal of Hepatology
- Vol. 32 (2) , 363-364
- https://doi.org/10.1016/s0168-8278(00)80087-2
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Targeting of Hepatitis C Virus Core Protein for MHC I or MHC II Presentation Does Not Enhance Induction of Immune Responses to DNA VaccinationDNA and Cell Biology, 1999
- DNA vaccine strategies for hepatitis CJournal of Hepatology, 1999
- Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.Journal of Clinical Investigation, 1997
- HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout MiceThe Journal of Experimental Medicine, 1997
- Sequence analysis of the core gene of 14 hepatitis C virus genotypes.Proceedings of the National Academy of Sciences, 1994